(CG) Carlyle - Ratings and Ratios
Private Equity, Real Assets, Credit, Infrastructure, Venture
CG EPS (Earnings per Share)
CG Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 36.7% |
| Value at Risk 5%th | 59.3% |
| Relative Tail Risk | -1.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.29 |
| Alpha | -15.49 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.414 |
| Beta | 1.722 |
| Beta Downside | 2.107 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.53% |
| Mean DD | 11.12% |
| Median DD | 9.38% |
Description: CG Carlyle October 16, 2025
The Carlyle Group Inc. (NASDAQ: CG) is a global alternative-asset manager that deploys capital through both direct investments and fund-of-fund structures, targeting a broad spectrum of strategies from leveraged buyouts and distressed credit to venture-stage growth and structured finance.
Its operations are organized into four core segments-Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions-allowing it to invest across more than 30 industries, including industrial manufacturing, aerospace & defense, fintech, renewable energy, and consumer retail. This diversification lets Carlyle capture value from macro-driven trends such as infrastructure spending, ESG-focused capital flows, and the ongoing digital transformation of traditional sectors.
As of the most recent filing, Carlyle reported approximately $426 billion in assets under management, generating $5.2 billion of revenue in 2023 with a net income margin of roughly 12 %, while fee-related earnings grew 8 % year-over-year, reflecting strong fundraising momentum and higher fee-related earnings from its expanding private-equity and real-asset platforms. For investors seeking deeper quantitative analysis, a look-up on ValueRay can provide granular, up-to-date performance metrics and scenario modeling tools.
CG Stock Overview
| Market Cap in USD | 18,880m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2012-05-03 |
| Return 12m vs S&P 500 | -5.85% |
| Analyst Rating | 3.56 of 5 |
CG Dividends
| Dividend Yield | 3.28% |
| Yield on Cost 5y | 7.20% |
| Yield CAGR 5y | 8.78% |
| Payout Consistency | 91.2% |
| Payout Ratio | 35.6% |
CG Growth Ratios
| CAGR 3y | 28.11% |
| CAGR/Max DD Calmar Ratio | 0.73 |
| CAGR/Mean DD Pain Ratio | 2.53 |
| Current Volume | 4221.9k |
| Average Volume | 2880.1k |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (937.5m TTM) > 0 and > 6% of Revenue (6% = 220.6m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 4.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -116.5% (prev -106.3%; Δ -10.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 969.3m > Net Income 937.5m (YES >=105%, WARN >=100%) |
| Net Debt (9.40b) to EBITDA (1.50b) ratio: 6.29 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (376.5m) change vs 12m ago 2.62% (target <= -2.0% for YES) |
| Gross Margin 90.32% (prev 71.80%; Δ 18.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 14.91% (prev 9.94%; Δ 4.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.95 (EBITDA TTM 1.50b / Interest Expense TTM 688.1m) >= 6 (WARN >= 3) |
Altman Z'' -0.35
| (A) -0.16 = (Total Current Assets 2.07b - Total Current Liabilities 6.35b) / Total Assets 27.06b |
| (B) 0.07 = Retained Earnings (Balance) 1.95b / Total Assets 27.06b |
| (C) 0.05 = EBIT TTM 1.34b / Avg Total Assets 24.67b |
| (D) 0.09 = Book Value of Equity 1.76b / Total Liabilities 20.21b |
| Total Rating: -0.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.62
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 3.14% = 1.57 |
| 3. FCF Margin 24.18% = 6.05 |
| 4. Debt/Equity 1.85 = 0.99 |
| 5. Debt/Ebitda 6.29 = -2.50 |
| 6. ROIC - WACC (= 3.40)% = 4.25 |
| 7. RoE 15.91% = 1.33 |
| 8. Rev. Trend 4.78% = 0.36 |
| 9. EPS Trend 41.54% = 2.08 |
What is the price of CG shares?
Over the past week, the price has changed by +2.40%, over one month by -9.92%, over three months by -16.83% and over the past year by +7.92%.
Is Carlyle a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CG is around 51.34 USD . This means that CG is currently overvalued and has a potential downside of -3.73%.
Is CG a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.2 | 24.1% |
| Analysts Target Price | 66.2 | 24.1% |
| ValueRay Target Price | 57.1 | 7.1% |
CG Fundamental Data Overview November 11, 2025
P/E Trailing = 29.4551
P/E Forward = 12.4378
P/S = 5.8848
P/B = 3.8093
P/EG = 0.9788
Beta = 2.057
Revenue TTM = 3.68b USD
EBIT TTM = 1.34b USD
EBITDA TTM = 1.50b USD
Long Term Debt = 12.43b USD (estimated: total debt 12.66b - short term 232.4m)
Short Term Debt = 232.4m USD (from shortTermDebt, last quarter)
Debt = 12.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.40b USD (from netDebt column, last quarter)
Enterprise Value = 28.28b USD (18.88b + Debt 12.66b - CCE 3.26b)
Interest Coverage Ratio = 1.95 (Ebit TTM 1.34b / Interest Expense TTM 688.1m)
FCF Yield = 3.14% (FCF TTM 889.3m / Enterprise Value 28.28b)
FCF Margin = 24.18% (FCF TTM 889.3m / Revenue TTM 3.68b)
Net Margin = 25.49% (Net Income TTM 937.5m / Revenue TTM 3.68b)
Gross Margin = 90.32% ((Revenue TTM 3.68b - Cost of Revenue TTM 356.0m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 82.51%)
Tobins Q-Ratio = 1.05 (Enterprise Value 28.28b / Total Assets 27.06b)
Interest Expense / Debt = 1.57% (Interest Expense 198.8m / Debt 12.66b)
Taxrate = -31.12% (negative due to tax credits) (-26.7m / 85.8m)
NOPAT = 1.76b (EBIT 1.34b * (1 - -31.12%)) [negative tax rate / tax credits]
Current Ratio = 0.33 (Total Current Assets 2.07b / Total Current Liabilities 6.35b)
Debt / Equity = 1.85 (Debt 12.66b / totalStockholderEquity, last quarter 6.85b)
Debt / EBITDA = 6.29 (Net Debt 9.40b / EBITDA 1.50b)
Debt / FCF = 10.57 (Net Debt 9.40b / FCF TTM 889.3m)
Total Stockholder Equity = 5.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.47% (Net Income 937.5m / Total Assets 27.06b)
RoE = 15.91% (Net Income TTM 937.5m / Total Stockholder Equity 5.89b)
RoCE = 7.32% (EBIT 1.34b / Capital Employed (Equity 5.89b + L.T.Debt 12.43b))
RoIC = 11.62% (NOPAT 1.76b / Invested Capital 15.13b)
WACC = 8.22% (E(18.88b)/V(31.54b) * Re(12.36%) + D(12.66b)/V(31.54b) * Rd(1.57%) * (1-Tc(-0.31)))
Discount Rate = 12.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.15%
[DCF Debug] Terminal Value 53.76% ; FCFE base≈889.3m ; Y1≈583.9m ; Y5≈267.0m
Fair Price DCF = 8.48 (DCF Value 3.05b / Shares Outstanding 360.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 41.54 | EPS CAGR: -1.83% | SUE: -0.73 | # QB: 0
Revenue Correlation: 4.78 | Revenue CAGR: -21.74% | SUE: -0.54 | # QB: 0
Additional Sources for CG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle